Integrated Biosensor Platform for Nucleic Acids Extraction and Detection.
Clicks: 369
ID: 89093
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
369 views
36 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #4 of 32 articles by views in Biotechnology and bioengineering
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The development of portable systems for nucleic acids (NAs) analysis is crucial for the evolution of biosensing versus the future healthcare technologies. The integration of NAs extraction, purification and detection modules, properly actuated by microfluidics technologies is a key point for the development of portable diagnostic systems. In this paper we described an integrated biosensor platform based on silicon-plastic hybrid Lab-on-disk technology able to manage NAs extraction, purification and detection process in integrated format. The sample preparation process is performed by solid phase extraction technology using magnetic beads on plastic disk, while the detection through quantitative Real-Time PCR on miniaturized silicon device. The sample and reagents movements are actuated by centrifugal-force induced by disk actuator instrument. The assessment of the NAs extraction and detection performances has been carried out by using Hepatitis B virus (HBV) DNA genome as biological target. Quantification of the qRT-PCR chip in the hybrid disk showed an improvement in sensitivity respect to the qRT-PCR commercial platforms, which means an optimization of time and costs. Limit of Detection (LoD) and a Limit of Quantification (LoQ) values of about 8 cps/reaction and 26 cps/reaction, respectively, were found by using analytical samples (synthetic clone), while the results with real samples (serum with spiked HBV genome) indicates the system performs as well as the standard methods. This article is protected by copyright. All rights reserved.
| Reference Key |
sciuto2020integratedbiotechnology
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Sciuto, Emanuele Luigi;Petralia, Salvatore;Calabrese, Giovanna;Conoci, Sabrina; |
| Journal | Biotechnology and bioengineering |
| Year | 2020 |
| DOI |
10.1002/bit.27290
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.